.jpg "IQVIA Holdings Inc (NYSE: IQV)")
Today, a Director at IQVIA Holdings Inc (NYSE: IQV), John Connaughton, sold shares of IQV for $148.4M.
See today’s analyst top recommended stocks >>
Based on IQVIA Holdings Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $2.56 billion and quarterly net profit of $69 million. In comparison, last year the company earned revenue of $2.33 billion and had a net profit of $74 million. IQV’s market cap is $21.78B and the company has a P/E ratio of 17.29. Currently, IQVIA Holdings Inc has an average volume of 2.72M.
Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $116.50, reflecting a -10.3% downside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IQVIA Holdings, Inc. is a biotechnology company, which engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries. The company was founded by Dennis Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
